Cargando…

The global burden and associated factors of ovarian cancer in 1990–2019: findings from the Global Burden of Disease Study 2019

BACKGROUND: Ovarian cancer (OC) is a major cause of cancer-related deaths among women. The aim of this study was to estimate and report data on the current burden of ovarian cancer worldwide over the past 30 years. METHOD: Based on the data provided by GBD 2019, we collected and interpreted the dise...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shiwen, Cheng, Chen, Lin, Zejian, Xiao, Linzi, Su, Xin, Zheng, Lu, Mu, Yingjun, Liao, Minqi, Ouyang, Ruiqing, Li, Wanlin, Ma, Junrong, Cai, Jun, Liu, Lu, Wang, Donghong, Zeng, Fangfang, Liu, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339194/
https://www.ncbi.nlm.nih.gov/pubmed/35907822
http://dx.doi.org/10.1186/s12889-022-13861-y
_version_ 1784760140577112064
author Zhang, Shiwen
Cheng, Chen
Lin, Zejian
Xiao, Linzi
Su, Xin
Zheng, Lu
Mu, Yingjun
Liao, Minqi
Ouyang, Ruiqing
Li, Wanlin
Ma, Junrong
Cai, Jun
Liu, Lu
Wang, Donghong
Zeng, Fangfang
Liu, Jun
author_facet Zhang, Shiwen
Cheng, Chen
Lin, Zejian
Xiao, Linzi
Su, Xin
Zheng, Lu
Mu, Yingjun
Liao, Minqi
Ouyang, Ruiqing
Li, Wanlin
Ma, Junrong
Cai, Jun
Liu, Lu
Wang, Donghong
Zeng, Fangfang
Liu, Jun
author_sort Zhang, Shiwen
collection PubMed
description BACKGROUND: Ovarian cancer (OC) is a major cause of cancer-related deaths among women. The aim of this study was to estimate and report data on the current burden of ovarian cancer worldwide over the past 30 years. METHOD: Based on the data provided by GBD 2019, we collected and interpreted the disease data of ovarian cancer by incidence, mortality, disability-adjusted life-years (DALYs), and used corresponding age-standardized rates as indicators. Also, we categorized the data by attributed risk factors and captured deaths due to high fasting plasma glucose, occupational exposure to asbestos and high body-mass index, respectively. All outcomes in the study were reported using mean values and corresponding 95% uncertainty intervals (95% UI). RESULTS: Globally, there were 294422 (260649 to 329727) incident cases in 2019, and the number of deaths and DALYs were 198412 (175357 to 217665) and 5.36 million (4.69 to 5.95). The overall burden was on the rise, with a percentage change of 107.8% (76.1 to 135.7%) for new cases, 103.8% (75.7 to 126.4%) for deaths and 96.1% (65.0 to 120.5%) for DALYs. Whereas the age-standardized rates kept stable during 1990–2019. The burden of ovarian cancer increased with age. and showed a totally different trends among SDI regions. Although high SDI region had the declining rates, the burden of ovarian cancer remained stable in high-middle and low SDI regions, and the middle and low-middle SDI areas showed increasing trends. High fasting plasma glucose was estimated to be the most important attributable risk factor for ovarian cancer deaths globally, with a percentage change of deaths of 7.9% (1.6 to 18.3%), followed by occupational exposure to asbestos and high body mass index. CONCLUSIONS: Although the age-standardized rates of ovarian cancer didn’t significantly change at the global level, the burden still increased, especially in areas on the lower end of the SDI range. Also, the disease burden due to different attributable risk factors showed heterogeneous, and it became more severe with age. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-022-13861-y.
format Online
Article
Text
id pubmed-9339194
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-93391942022-08-01 The global burden and associated factors of ovarian cancer in 1990–2019: findings from the Global Burden of Disease Study 2019 Zhang, Shiwen Cheng, Chen Lin, Zejian Xiao, Linzi Su, Xin Zheng, Lu Mu, Yingjun Liao, Minqi Ouyang, Ruiqing Li, Wanlin Ma, Junrong Cai, Jun Liu, Lu Wang, Donghong Zeng, Fangfang Liu, Jun BMC Public Health Research BACKGROUND: Ovarian cancer (OC) is a major cause of cancer-related deaths among women. The aim of this study was to estimate and report data on the current burden of ovarian cancer worldwide over the past 30 years. METHOD: Based on the data provided by GBD 2019, we collected and interpreted the disease data of ovarian cancer by incidence, mortality, disability-adjusted life-years (DALYs), and used corresponding age-standardized rates as indicators. Also, we categorized the data by attributed risk factors and captured deaths due to high fasting plasma glucose, occupational exposure to asbestos and high body-mass index, respectively. All outcomes in the study were reported using mean values and corresponding 95% uncertainty intervals (95% UI). RESULTS: Globally, there were 294422 (260649 to 329727) incident cases in 2019, and the number of deaths and DALYs were 198412 (175357 to 217665) and 5.36 million (4.69 to 5.95). The overall burden was on the rise, with a percentage change of 107.8% (76.1 to 135.7%) for new cases, 103.8% (75.7 to 126.4%) for deaths and 96.1% (65.0 to 120.5%) for DALYs. Whereas the age-standardized rates kept stable during 1990–2019. The burden of ovarian cancer increased with age. and showed a totally different trends among SDI regions. Although high SDI region had the declining rates, the burden of ovarian cancer remained stable in high-middle and low SDI regions, and the middle and low-middle SDI areas showed increasing trends. High fasting plasma glucose was estimated to be the most important attributable risk factor for ovarian cancer deaths globally, with a percentage change of deaths of 7.9% (1.6 to 18.3%), followed by occupational exposure to asbestos and high body mass index. CONCLUSIONS: Although the age-standardized rates of ovarian cancer didn’t significantly change at the global level, the burden still increased, especially in areas on the lower end of the SDI range. Also, the disease burden due to different attributable risk factors showed heterogeneous, and it became more severe with age. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-022-13861-y. BioMed Central 2022-07-30 /pmc/articles/PMC9339194/ /pubmed/35907822 http://dx.doi.org/10.1186/s12889-022-13861-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zhang, Shiwen
Cheng, Chen
Lin, Zejian
Xiao, Linzi
Su, Xin
Zheng, Lu
Mu, Yingjun
Liao, Minqi
Ouyang, Ruiqing
Li, Wanlin
Ma, Junrong
Cai, Jun
Liu, Lu
Wang, Donghong
Zeng, Fangfang
Liu, Jun
The global burden and associated factors of ovarian cancer in 1990–2019: findings from the Global Burden of Disease Study 2019
title The global burden and associated factors of ovarian cancer in 1990–2019: findings from the Global Burden of Disease Study 2019
title_full The global burden and associated factors of ovarian cancer in 1990–2019: findings from the Global Burden of Disease Study 2019
title_fullStr The global burden and associated factors of ovarian cancer in 1990–2019: findings from the Global Burden of Disease Study 2019
title_full_unstemmed The global burden and associated factors of ovarian cancer in 1990–2019: findings from the Global Burden of Disease Study 2019
title_short The global burden and associated factors of ovarian cancer in 1990–2019: findings from the Global Burden of Disease Study 2019
title_sort global burden and associated factors of ovarian cancer in 1990–2019: findings from the global burden of disease study 2019
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339194/
https://www.ncbi.nlm.nih.gov/pubmed/35907822
http://dx.doi.org/10.1186/s12889-022-13861-y
work_keys_str_mv AT zhangshiwen theglobalburdenandassociatedfactorsofovariancancerin19902019findingsfromtheglobalburdenofdiseasestudy2019
AT chengchen theglobalburdenandassociatedfactorsofovariancancerin19902019findingsfromtheglobalburdenofdiseasestudy2019
AT linzejian theglobalburdenandassociatedfactorsofovariancancerin19902019findingsfromtheglobalburdenofdiseasestudy2019
AT xiaolinzi theglobalburdenandassociatedfactorsofovariancancerin19902019findingsfromtheglobalburdenofdiseasestudy2019
AT suxin theglobalburdenandassociatedfactorsofovariancancerin19902019findingsfromtheglobalburdenofdiseasestudy2019
AT zhenglu theglobalburdenandassociatedfactorsofovariancancerin19902019findingsfromtheglobalburdenofdiseasestudy2019
AT muyingjun theglobalburdenandassociatedfactorsofovariancancerin19902019findingsfromtheglobalburdenofdiseasestudy2019
AT liaominqi theglobalburdenandassociatedfactorsofovariancancerin19902019findingsfromtheglobalburdenofdiseasestudy2019
AT ouyangruiqing theglobalburdenandassociatedfactorsofovariancancerin19902019findingsfromtheglobalburdenofdiseasestudy2019
AT liwanlin theglobalburdenandassociatedfactorsofovariancancerin19902019findingsfromtheglobalburdenofdiseasestudy2019
AT majunrong theglobalburdenandassociatedfactorsofovariancancerin19902019findingsfromtheglobalburdenofdiseasestudy2019
AT caijun theglobalburdenandassociatedfactorsofovariancancerin19902019findingsfromtheglobalburdenofdiseasestudy2019
AT liulu theglobalburdenandassociatedfactorsofovariancancerin19902019findingsfromtheglobalburdenofdiseasestudy2019
AT wangdonghong theglobalburdenandassociatedfactorsofovariancancerin19902019findingsfromtheglobalburdenofdiseasestudy2019
AT zengfangfang theglobalburdenandassociatedfactorsofovariancancerin19902019findingsfromtheglobalburdenofdiseasestudy2019
AT liujun theglobalburdenandassociatedfactorsofovariancancerin19902019findingsfromtheglobalburdenofdiseasestudy2019
AT zhangshiwen globalburdenandassociatedfactorsofovariancancerin19902019findingsfromtheglobalburdenofdiseasestudy2019
AT chengchen globalburdenandassociatedfactorsofovariancancerin19902019findingsfromtheglobalburdenofdiseasestudy2019
AT linzejian globalburdenandassociatedfactorsofovariancancerin19902019findingsfromtheglobalburdenofdiseasestudy2019
AT xiaolinzi globalburdenandassociatedfactorsofovariancancerin19902019findingsfromtheglobalburdenofdiseasestudy2019
AT suxin globalburdenandassociatedfactorsofovariancancerin19902019findingsfromtheglobalburdenofdiseasestudy2019
AT zhenglu globalburdenandassociatedfactorsofovariancancerin19902019findingsfromtheglobalburdenofdiseasestudy2019
AT muyingjun globalburdenandassociatedfactorsofovariancancerin19902019findingsfromtheglobalburdenofdiseasestudy2019
AT liaominqi globalburdenandassociatedfactorsofovariancancerin19902019findingsfromtheglobalburdenofdiseasestudy2019
AT ouyangruiqing globalburdenandassociatedfactorsofovariancancerin19902019findingsfromtheglobalburdenofdiseasestudy2019
AT liwanlin globalburdenandassociatedfactorsofovariancancerin19902019findingsfromtheglobalburdenofdiseasestudy2019
AT majunrong globalburdenandassociatedfactorsofovariancancerin19902019findingsfromtheglobalburdenofdiseasestudy2019
AT caijun globalburdenandassociatedfactorsofovariancancerin19902019findingsfromtheglobalburdenofdiseasestudy2019
AT liulu globalburdenandassociatedfactorsofovariancancerin19902019findingsfromtheglobalburdenofdiseasestudy2019
AT wangdonghong globalburdenandassociatedfactorsofovariancancerin19902019findingsfromtheglobalburdenofdiseasestudy2019
AT zengfangfang globalburdenandassociatedfactorsofovariancancerin19902019findingsfromtheglobalburdenofdiseasestudy2019
AT liujun globalburdenandassociatedfactorsofovariancancerin19902019findingsfromtheglobalburdenofdiseasestudy2019